BACKGROUND: Medication development for alcoholism typically includes experimental pharmacology studies with non-treatment-seeking individuals with alcohol use disorder (AUD) paving the way for randomized controlled trials in treatment-seekers with AUD. OBJECTIVES: The goal of this study is to provide a direct comparison between AUD treatment-seeking research participants and non-treatment-seeking participants on demographic and clinical variables and to test whether variables that differentiate the two groups are associated with clinical outcomes. METHOD: Non-treatment-seeking AUD participants (n = 213; 76.3% male) who completed behavioral pharmacology studies were compared to treatment-seekers who completed the COMBINE Study (n = 1383; 69.1% male) on demographic and clinical variables. Analyses examined whether the variables that differentiated the two groups predicted treatment outcomes in the COMBINE Study. RESULTS: Analyses revealed that treatment-seeking participants were older, had more years of education, higher Alcohol Dependence Scale scores, higher Drinker Inventory of Consequences scores, higher Obsessive Compulsive Drinking Scale scores, a greater number of DSM-IV symptoms of AUD, longer duration of AUD, and consumed more standard drinks and more drinks per drinking day (i.e., in the past 30 days) compared to non-treatment-seeking participants. Nearly all characteristics that differed between the groups predicted at least one of the primary clinical outcomes of the COMBINE Study. CONCLUSIONS: This study highlights a host of clinical and demographic factors that differ between non-treatment-seeking and treatment-seeking research participants and the clinical significance of these variables. Differences between samples should be considered and addressed in order to promote greater consilience across stages of medication development.
BACKGROUND: Medication development for alcoholism typically includes experimental pharmacology studies with non-treatment-seeking individuals with alcohol use disorder (AUD) paving the way for randomized controlled trials in treatment-seekers with AUD. OBJECTIVES: The goal of this study is to provide a direct comparison between AUD treatment-seeking research participants and non-treatment-seeking participants on demographic and clinical variables and to test whether variables that differentiate the two groups are associated with clinical outcomes. METHOD: Non-treatment-seeking AUD participants (n = 213; 76.3% male) who completed behavioral pharmacology studies were compared to treatment-seekers who completed the COMBINE Study (n = 1383; 69.1% male) on demographic and clinical variables. Analyses examined whether the variables that differentiated the two groups predicted treatment outcomes in the COMBINE Study. RESULTS: Analyses revealed that treatment-seeking participants were older, had more years of education, higher Alcohol Dependence Scale scores, higher Drinker Inventory of Consequences scores, higher Obsessive Compulsive Drinking Scale scores, a greater number of DSM-IV symptoms of AUD, longer duration of AUD, and consumed more standard drinks and more drinks per drinking day (i.e., in the past 30 days) compared to non-treatment-seeking participants. Nearly all characteristics that differed between the groups predicted at least one of the primary clinical outcomes of the COMBINE Study. CONCLUSIONS: This study highlights a host of clinical and demographic factors that differ between non-treatment-seeking and treatment-seeking research participants and the clinical significance of these variables. Differences between samples should be considered and addressed in order to promote greater consilience across stages of medication development.
Entities:
Keywords:
Treatment-seeking; alcohol use disorder; alcoholism; behavioral pharmacology; clinical trials
Authors: Matthew J Worley; Katie Witkiewitz; Sandra A Brown; Daniel R Kivlahan; Richard Longabaugh Journal: Alcohol Clin Exp Res Date: 2015-01 Impact factor: 3.455
Authors: Karl Mann; Tagrid Lemenager; Sabine Hoffmann; Iris Reinhard; Derik Hermann; Anil Batra; Michael Berner; Norbert Wodarz; Andreas Heinz; Michael N Smolka; Ulrich S Zimmermann; Stefan Wellek; Falk Kiefer; Raymond F Anton Journal: Addict Biol Date: 2012-12-12 Impact factor: 4.280
Authors: Raye Z Litten; Mark Egli; Markus Heilig; Changhai Cui; Joanne B Fertig; Megan L Ryan; Daniel E Falk; Howard Moss; Robert Huebner; Antonio Noronha Journal: Addict Biol Date: 2012-03-28 Impact factor: 4.280
Authors: Raymond F Anton; Stephanie S O'Malley; Domenic A Ciraulo; Ron A Cisler; David Couper; Dennis M Donovan; David R Gastfriend; James D Hosking; Bankole A Johnson; Joseph S LoCastro; Richard Longabaugh; Barbara J Mason; Margaret E Mattson; William R Miller; Helen M Pettinati; Carrie L Randall; Robert Swift; Roger D Weiss; Lauren D Williams; Allen Zweben Journal: JAMA Date: 2006-05-03 Impact factor: 56.272
Authors: Meenakshi Sabina Subbaraman; Samuel Lendle; Mark van der Laan; Lee Ann Kaskutas; Jennifer Ahern Journal: Addiction Date: 2013-06-04 Impact factor: 6.526
Authors: Hollis C Karoly; Joseph P Schacht; Joanna Jacobus; Lindsay R Meredith; Charles T Taylor; Susan F Tapert; Kevin M Gray; Lindsay M Squeglia Journal: Drug Alcohol Depend Date: 2019-05-14 Impact factor: 4.492
Authors: Samuel W Stull; Leigh V Panlilio; Landhing M Moran; Jennifer R Schroeder; Jeremiah W Bertz; David H Epstein; Kenzie L Preston; Karran A Phillips Journal: Addict Behav Date: 2019-04-29 Impact factor: 3.913
Authors: Joseph P Schacht; Konstantin E Voronin; Patrick K Randall; Raymond F Anton Journal: Neuropsychopharmacology Date: 2017-12-06 Impact factor: 7.853
Authors: Dylan K Richards; Osvaldo F Morera; José A Cabriales; Juliana Cardoso Smith; Craig A Field Journal: Alcohol Alcohol Date: 2020-06-25 Impact factor: 2.826